Meeting Abstract
Autorenliste: Yoo, D. H.; Racewicz, A.; Brzezicki, J.; Yatsyshyn, R.; Arteaga, E. Tobias; Baranauskaite, A.; Abud-Mendoza, C.; Navarra, S.; Eullaran, R.; Kadinov, V.; Sariego, I. Goecke; Byrne, P.; Park, W.; Lee, S. J.; Kim, H. U.; Mueller-Ladner, U.
Jahr der Veröffentlichung: 2013
Seiten: 73-73
Zeitschrift: Annals of the Rheumatic Diseases
Bandnummer: 72
ISSN: 0003-4967
eISSN: 1468-2060
Konferenz: Annual European Congress of Rheumatology (EULAR)
Verlag: Elsevier
Zitierstile
Harvard-Zitierstil: Yoo, D., Racewicz, A., Brzezicki, J., Yatsyshyn, R., Arteaga, E., Baranauskaite, A., et al. (2013) A PHASE 3 RANDOMISED CONTROLLED TRIAL TO COMPARE CT-P13 WITH INFLIXIMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: 54 WEEK RESULTS FROM THE PLANETRA STUDY, Annals of the Rheumatic Diseases, 72, p. 73
APA-Zitierstil: Yoo, D., Racewicz, A., Brzezicki, J., Yatsyshyn, R., Arteaga, E., Baranauskaite, A., Abud-Mendoza, C., Navarra, S., Eullaran, R., Kadinov, V., Sariego, I., Byrne, P., Park, W., Lee, S., Kim, H., & Mueller-Ladner, U. (2013). A PHASE 3 RANDOMISED CONTROLLED TRIAL TO COMPARE CT-P13 WITH INFLIXIMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: 54 WEEK RESULTS FROM THE PLANETRA STUDY. Annals of the Rheumatic Diseases. 72, 73.
